31 results on '"Urtasun, Raul"'
Search Results
2. Dr. Felix Leborgne, 1935–2009
3. Assessment of Extended-Field Radiotherapy for Stage IIIC Endometrial Cancer Using Three-Dimensional Conformal Radiotherapy, Intensity-Modulated Radiotherapy, and Helical Tomotherapy
4. Phase III randomized study of radiotherapy plus procarbazine, lomustine, and vincristine with or without BUdR for treatment of anaplastic astrocytoma: final report of RTOG 9404
5. The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data
6. E-15. Imaging hypoxic micro-regions of lung cancers
7. A phase 3 randomized study of radiotherapy plus procarbazine, CCNU, and vincristine (PCV) with or without BUdR for the treatment of anaplastic astrocytoma: a preliminary report of RTOG 9404
8. Intervention with the hypoxic tumor cell sensitizer etanidazole in the combined modality treatment of limited stage small-cell lung cancer. A one-institution study
9. Quality of life and neuropsychological evaluation for patients with malignant astrocytomas: RTOG 91-14
10. 122 Failure patterns by prognostic group as determined by recursive partitioning analysis (RPA) of 1547 on four radiation therapy oncology group studies in operable non-small cell lung cancer(NSCLC)
11. 2161 The impact of radiation dose and fractionation on the risk factor of radiation pneumonitis on four radiation therapy oncology group (RTOG) lung cancer trials
12. Survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: Final report of RTOG 86-12, phase I–II study
13. 3 Imaging response is highly predictive of survival of malignant glioma patients treated with standard or hyperfractionated RT and carmustine in RTOG 9006
14. 102 The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non-small cell lung cancer: An RTOG analysis
15. 4 Validation and predictive power of radiation therapy oncology group (RTOG) recursive partitioning analysis classes for malignant glioma patients: A report using RTOG 90-06
16. A Radiation Therapy Oncology Group experience: chemotherapy/radiation therapy of lung cancer
17. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme
18. Radiosensitivity testing of human primary brain tumor specimens
19. Heterogeneity in response to treatment with buthionine sulfoximine or interferon in human malignant glioma cells
20. A randomized phase iii protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916)
21. Final report of the phase i trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) radiation therapy oncology group 83-03
22. Tumor growth delay studies in patients with multiple metastatic nodules: Practical difficulties
23. Hypofractionated radiotherapy with or without misonidazole for the treatment of brain metastases
24. Hyperfractionation in the radiation therapy of unresectable non-oat cell carcinoma of the lung: Preliminary report of a RTOG pilot study
25. Initial report of the phase I trial of the hypoxic cell radiosensitizer SR-2508
26. Results of the phase I trial of the hypoxic cell radiosensitizer SR 2508
27. Phase I trial of the hypoxic cell radiosensitizer SR-2508: The results of the five to six week drug schedule
28. Cytotoxic and radiosensitizing effects of misonidazole on hematopoiesis in normal and tumor-bearing mice
29. A randomized phase III protocol for the evaluation of misonidazole with radiation in the treatment of patients with brain metastasis (RTOG-7916)
30. Initial pharmacology and toxicology of intravenous desmethylmisonidazole
31. Clinical trials with hypoxic cell sensitizers: Time to retrench or time to push forward?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.